An organoid is a three-dimensional(3D)cell culture model that can reproduce the distinct structure and inherent functionality of certain organs.Nevertheless,a major limitation of organoids is the absence of a complex ...An organoid is a three-dimensional(3D)cell culture model that can reproduce the distinct structure and inherent functionality of certain organs.Nevertheless,a major limitation of organoids is the absence of a complex vascular network,thus restricting the supply of oxygen and essential nutrients.Coupled with their inherent size constraints and metabolite accumulation,it is challenging for organoids to replicate the natural intricacies of organs,thereby limiting their applicability.To overcome the challenges associated with this technology,we developed a culture platform to cultivate tumors or organ-derived organoids up to the centimeter scale.Initially,a customized organoid-on-a-chip including a microvascular network at the micron scale was designed using 3D printing.Further,by integrating an infusion device,the chip ensures an adequate supply of nutrients and fluid immersion while mimicking blood flow dynamics.Our method overcomes the issue of the limited size of organoids due to insufficient nutrient access,making it possible to produce large-scale tumor and normal tissue models in vitro,while providing insights into drug efficacy and toxicology evaluation as well as standardized organoid production.展开更多
基金supported by the National Key Research and Development Program of China(No.2024YFA1300128)the National Natural Science Foundation of China(No.82372663)+2 种基金the Key Research and Development Program of Yunnan Province(No.202302AA310024)the Key Research and Development Program of Jiangxi Province(No.20232BBG70024)the Natural Science Foundation of Shandong Province(No.ZR2023LSW008).
文摘An organoid is a three-dimensional(3D)cell culture model that can reproduce the distinct structure and inherent functionality of certain organs.Nevertheless,a major limitation of organoids is the absence of a complex vascular network,thus restricting the supply of oxygen and essential nutrients.Coupled with their inherent size constraints and metabolite accumulation,it is challenging for organoids to replicate the natural intricacies of organs,thereby limiting their applicability.To overcome the challenges associated with this technology,we developed a culture platform to cultivate tumors or organ-derived organoids up to the centimeter scale.Initially,a customized organoid-on-a-chip including a microvascular network at the micron scale was designed using 3D printing.Further,by integrating an infusion device,the chip ensures an adequate supply of nutrients and fluid immersion while mimicking blood flow dynamics.Our method overcomes the issue of the limited size of organoids due to insufficient nutrient access,making it possible to produce large-scale tumor and normal tissue models in vitro,while providing insights into drug efficacy and toxicology evaluation as well as standardized organoid production.
